孤立性视网膜动脉阻塞后卒中复发风险低于轻微卒中或短暂性脑缺血发作
这项回顾性队列研究基于美国2016至2022年全国再入院数据库,比较非动脉炎性孤立性视网膜动脉阻塞(iRAO)与非致残性缺血性脑血管事件(NICE)后300天内脑梗死风险。经倾向评分匹配后,iRAO组后续脑梗死风险显著低于NICE组(HR 0.26,95%CI 0.20-0.35,P<0.001),提示iRAO在后续卒中风险上不等同于缺血性脑血管事件。
要点
- 非动脉炎性iRAO后300天内脑梗死风险显著低于NICE(HR 0.26)。
- iRAO组30、90、180天脑梗死绝对发生率均低于NICE组。
- iRAO的二级卒中预防策略可能需要区别于NICE。
核心结论
- 非动脉炎性孤立性视网膜动脉阻塞(iRAO)后后续脑梗死风险显著低于非致残性缺血性脑血管事件(NICE)。
- iRAO事件在后续卒中风险上不等同于缺血性脑血管事件。
研究设计与样本
- 回顾性队列研究,使用美国2016至2022年全国再入院数据库。
- 纳入因RAO或NICE主要住院的成人,排除出院时功能依赖、中重度卒中(NIHSS>4)、动脉炎或血管炎、RAO合并脑梗死者。
- 采用2:1倾向评分匹配平衡基线特征,主要结局为300天内后续脑梗死。
主要发现
- 共识别1 673 145例因非致残性卒中、TIA或RAO住院患者,其中17 388例(1.0%)为RAO,4507例(25.9%)合并脑梗死被排除。
- 匹配后纳入11 185例非动脉炎性iRAO和22 757例NICE患者。
- iRAO组后续脑梗死风险显著低于NICE组(HR 0.26,95%CI 0.20-0.35,P<0.001)。
- 30、90、180天脑梗死绝对发生率iRAO vs NICE分别为0.5% vs 2.3%、0.8% vs 3.1%、1.2% vs 4.3%(均P<0.001)。
临床怎么用
- 临床评估iRAO患者时,不应直接套用NICE的二级卒中预防策略。
- 需针对非动脉炎性iRAO制定个体化二级卒中预防方案。
局限性
- 研究为回顾性队列设计,可能存在残余混杂。
- 需进一步研究优化针对非动脉炎性iRAO的二级卒中预防策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Retinal artery occlusion (RAO) is a form of ischemic stroke per the American Heart Association, yet high-level evidence guiding management and prognostication is limited. The risk of future cerebral infarction following nonarteritic isolated RAO (iRAO; without concomitant cerebral infarction) is unclear. This study compares the risk of stroke recurrence following iRAO versus nondisabling ischemic cerebrovascular events (NICEs), including transient ischemic attacks and minor ischemic strokes. METHODS: This was a retrospective cohort study using the 2016 to 2022 Nationwide Readmissions Database in the United States. Adults hospitalized primarily for RAO or NICE were included. Patients who were functionally dependent at discharge or had moderate to severe stroke (National Institutes of Health Stroke Scale score >4), arteritis or vasculitis, or RAO and concomitant cerebral infarction were excluded from the primary analysis. Two-to-one propensity score matching was performed to balance baseline characteristics between cohorts. The primary outcome was subsequent cerebral infarction within 300 days. Cox regression models and multivariable adjustments were used to estimate hazard ratios. RESULTS: A total of 1 673 145 patients hospitalized for nondisabling stroke, transient ischemic attack, or RAO were identified; 17 388 (1.0%) had RAO, of whom 4507 (25.9%) had concomitant cerebral infarction and were excluded for primary analyses. After applying additional exclusion criteria and propensity score matching, 11 185 patients with nonarteritic iRAO and 22 757 patients with NICE remained. Patients with iRAO had a significantly lower risk of subsequent cerebral infarction (hazard ratio, 0.26 [95% CI, 0.20-0.35]; P<0.001). Absolute cerebral infarction rates at 30, 90, and 180 days were lower in patients with iRAO versus patients with NICE (0.5% versus 2.3%, 0.8% versus 3.1%, and 1.2% versus 4.3%, respectively; all P<0.001 for all). CONCLUSIONS: Nonarteritic iRAO events were associated with significantly lower risks of subsequent cerebral infarction compared with NICE. These findings suggest that iRAO events are not equivalent to ischemic cerebrovascular events in terms of risk of subsequent stroke. Further studies are needed to optimize secondary stroke prevention strategies tailored to nonarteritic iRAOs.
引用
- Chen H, Colasurdo M, Falardeau J, et al. Risk of Stroke Recurrence Following Isolated Retinal Artery Occlusion Versus Minor Stroke or Transient Ischemic Attack. Stroke. 2025. PMID: 40905136. doi:10.1161/STROKEAHA.125.052738
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。